Article: Data Presented at American Diabetes Association Annual Meeting Suggest Testosterone Levels Correlate with Insulin Resistance and Insulin Sensitivity in Type 2 Diabetes Patients.

Findings from this analysis of diabetic patients call for more research to evaluate benefits of testosterone replacement therapy in Type 2 diabetes patients

MALVERN, Pa., June 12 /PRNewswire-FirstCall/ -- Auxilium Pharmaceuticals, Inc. , a specialty pharmaceutical company, announced that new findings presented today at the American Diabetes Association's 66th Annual Scientific Sessions suggest that abnormally low testosterone levels may be linked to progression of Type 2 diabetes. The data are obtained from patient screening for a prospective study and include 568 men with Type 2 diabetes. Researchers found a general increase in insulin resistance in patients ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!